Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/2/24 19:03 | 1/2/24 | ICVX | Health | BioPrd | Biological Products, (No Diag | Simpson Adam K. | WA | DO | CEO | 5 | S.dm | -3,000 | 14.89 | 0 | -201 | 1,142 | D | |||||||||||||||
1/5/24 19:18 | 1/4/23 | ICVX | Health | BioPrd | Biological Products, (No Diag | Kanesa-Thasan Niranjan | WA | O | Chief Me | 4 | S.d | -1,903 | 15.42 | 0 | -123 | 239 | D | |||||||||||||||
12/22/23 18:26 | 12/20/23 | ICVX | Health | BioPrd | Biological Products, (No Diag | Russo Thomas Joseph | WA | O | CFO | 3 | S | -282 | 14.01 | 0 | -20 | 49 | D | |||||||||||||||
12/22/23 18:24 | 12/20/23 | ICVX | Health | BioPrd | Biological Products, (No Diag | Cearley Cassia | WA | O | Chief Bu | 6 | S | -436 | 12.37 | 0 | -35 | 157 | D | |||||||||||||||
7/3/23 19:43 | 7/3/23 | ICVX | Health | BioPrd | Biological Products, (No Diag | Holtzman Douglas | WA | O | Chief Sc | 3 | S.dm | -319 | 7.67 | 0 | -42 | 293 | D | |||||||||||||||
2/15/23 20:12 | 2/13/23 | ICVX | Health | BioPrd | Biological Products, (No Diag | Bekiroglu Elizabeth | WA | O | GC,Corp. | 1 | S | -63 | 10.69 | 0 | -6 | 103 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |